Picard Medical, Inc. (PMI) Financial Statements
Picard Medical, Inc. (PMI) reported trailing twelve-month revenue of $6.3M (up 41.0% year on year) and net income of -$28.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PMIPicard Medical, Inc.Follow PMI — free
—
Price chart with a free account
- Market cap
- 16.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 13 Nov, in 20 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Revenue | 4.4 | 4.9 | 6.3 | |
| Gross profit | -0.1 | -0.2 | 1.2 | |
| Research & development | 3.4 | 3.0 | 4.8 | |
| Operating income | -13.7 | -13.3 | -15.6 | |
| Pre-tax income | -21.1 | -27.0 | -28.0 | |
| Income tax | -0.0 | 0.0 | 0.0 | |
| Net income | -21.1 | -27.0 | -28.0 |
USD millions · SEC XBRL
Picard Medical, Inc. — questions
- What is Picard Medical, Inc.'s revenue?
- $6.3M over the twelve months to 2026-06-30, up 41.0% year on year, from its 10-Q and 10-K filings.
- What is Picard Medical, Inc.'s net income?
- -$28.0M over the twelve months to 2026-06-30.
Every figure on this page comes from Picard Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.